Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Not for human consumption, medical, veterinary, or household use
Its outlook also includes adjusted EBITDA in a range of a $2 million loss to breakeven, up from a prior range of a $9 million to $5 million loss.
Neurotransmitter inhibitor peptides inhibit acetylcholine (Ach) release at the neuromuscular junction and have a curare-like effect, such as acetyl hexapeptide-8
Effect of enzymatic hydrolysis on cholesterol-lowering activity of oat beta-glucan
Point 3: Expect long-lasting volume-up effects for 1 to 2 years
US$ 22.03
US$ 22.69
US$ 26.27
US$ 23.18
